Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects

Molecular and Cellular Endocrinology

Volumn 275, Issue 1-2, 2007, Pages 13-29

  Kassel, Olivier ^a   Herrlich, Peter ^a,b  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

AP 1; Crosstalk; Glucocorticoid receptor; NF B; Trans repression; Transcription

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROLACTIN; STAT5 PROTEIN; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

DIMERIZATION; DNA BINDING; HORMONE BINDING; HUMAN; IMMUNOPRECIPITATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTOR CROSS-TALK; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 34547884315     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.07.003     Document Type: Review

References (160)

1. Adams M., Meijer O.C., Wang J., Bhargava A., and Pearce D. Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants. Mol. Endocrinol. 17 (2003) 2583-2592
2. Akerblom I.E., Slater E.P., Beato M., Baxter J.D., and Mellon P.L. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 241 (1988) 350-353
3. Arce L., Yokoyama N.N., and Waterman M.L. Diversity of LEF/TCF action in development disease. Oncogene 25 (2006) 7492-7504
4. Arias J., Alberts A.S., Brindle P., Claret F.X., Smeal T., Karin M., Feramisco J., and Montminy M. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370 (1994) 226-229
5. Ashburner B.P., Westerheide S.D., and Baldwin Jr. A.S. The p65 (RelA) Subunit of NF-κB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 21 (2001) 7065-7077
6. Bach I. The LIM domain: regulation by association. Mech. Dev. 91 (2000) 5-17
7. Bannister A.J., and Kouzarides T. Reversing histone methylation. Nature 436 (2005) 1103-1106
8. Bauer A., Tronche F., Wessely O., Kellendonk C., Reichardt H.M., Steinlein P., Schutz G., and Beug H. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev. 13 (1999) 2996-3002
9. Bilodeau S., Vallette-Kasic S., Gauthier Y., Figarella-Branger D., Brue T., Berthelet F., Lacroix A., Batista D., Stratakis C., Hanson J., Meij B., and Drouin J. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 20 (2006) 2871-2886
10. Biola A., Andreau K., David M., Sturm M., Haake M., Bertoglio J., and Pallardy M. The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS Lett. 487 (2000) 229-233
11. Biola A., Lefebvre P., Perrin-Wolff M., Sturm M., Bertoglio J., and Pallardy M. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Mol. Endocrinol. 15 (2001) 1062-1076
12. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., Millard H., Lambert M.H., Moore J.T., Pearce K.H., and Xu E.H. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110 (2002) 93-105
13. Bruggemeier U., Kalff M., Franke S., Scheidereit C., and Beato M. Ubiquitous transcription factor OTF-1 mediates induction of the MMTV promoter through synergistic interaction with hormone receptors. Cell 64 (1991) 565-572
14. Bruna A., Nicolas M., Munoz A., Kyriakis J.M., and Caelles C. Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J. 22 (2003) 6035-6044
15. Burkhart B.A., Hebbar P.B., Trotter K.W., and Archer T.K. Chromatin-dependent E1A activity modulates NF-kappaB RelA-mediated repression of glucocorticoid receptor-dependent transcription. J. Biol. Chem. 280 (2005) 6349-6358
16. Caelles C., Gonzalez-Sancho J.M., and Munoz A. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev. 11 (1997) 3351-3364
17. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J.A., and Van der Saag P.T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9 (1995) 401-412
18. Chan C., Li L., McCall C.E., and Yoza B.K. Endotoxin tolerance disrupts chromatin remodeling and NF-κB transactivation at the IL-1β promoter. J. Immunol. 175 (2005) 461-468
19. Charmandari E., Kino T., Souvatzoglou E., Vottero A., Bhattacharyya N., and Chrousos G.P. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. J. Clin. Endocr. Metab. 89 (2004) 1939-1949
20. Chatterjee V.K., Madison L.D., Mayo S., and Jameson J.L. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: evidence for receptor interactions with limiting transcriptional activators. Mol. Endocrinol. 5 (1991) 100-110
21. Coghlan M.J., Jacobson P.B., Lane B., Nakane M., Lin C.W., Elmore S.W., Kym P.R., Luly J.R., Carter G.W., Turner R., Tyree C.M., Hu J., Elgort M., Rosen J., and Miner J.N. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 17 (2003) 860-869
22. Covic M., Hassa P.O., Saccani S., Buerki C., Meier N.I., Lombardi C., Imhof R., Bedford M.T., Natoli G., and Hottiger M.O. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J. 24 (2005) 85-96
23. Dahlman-Wright K., Wright A., Gustafsson J.A., and Carlstedt-Duke J. Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J. Biol. Chem. 266 (1991) 3107-3112
24. Davis R.J. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42 (1995) 459-467
25. De Bosscher K., Schmitz M.L., Vanden Berghe W., Plaisance S., Fiers W., and Haegeman G. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13504-13509
26. De Bosscher K., Vanden Berghe W., and Haegeman G. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators. Mol. Endocrinol. 15 (2001) 219-227
27. De Bosscher K., Vanden Berghe W., Vermeulen L., Plaisance S., Boone E., and Haegeman G. Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 3919-3924
28. de Lange P., Koper J.W., Huizenga N.A., Brinkmann A.O., de Jong F.H., Karl M., Chrousos G.P., and Lamberts S.W. Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Mol. Endocrinol. 11 (1997) 1156-1164
29. de Martino M.U., Bhattachryya N., Alesci S., Ichijo T., Chrousos G.P., and Kino T. The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: implications for intermediary metabolism. Mol. Endocrinol. 18 (2004) 820-833
30. Diamond M.I., Miner J.N., Yoshinaga S.K., and Yamamoto K.R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249 (1990) 1266-1272
31. Doppler W., Windegger M., Soratroi C., Tomasi J., Lechner J., Rusconi S., Cato A.C., Almlof T., Liden J., Okret S., Gustafsson J.A., Richard-Foy H., Starr D.B., Klocker H., Edwards D., and Geymayer S. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5. Mol. Cell. Biol. 21 (2001) 3266-3279
32. Engblom D., Kornfeld J.-W., Schwake L., Tronche F., Reimann A., Beug H., Hennighausen L., Moriggl R., and Schütz G. Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev. 21 (2007) 1157-1162
33. Espinas M.L., Roux J., Ghysdael J., Pictet R., and Grange T. Participation of Ets transcription factors in the glucocorticoid response of the rat tyrosine aminotransferase gene. Mol. Cell. Biol. 14 (1994) 4116-4125
34. Garside H., Stevens A., Farrow S., Normand C., Houle B., Berry A., Maschera B., and Ray D. Glucocorticoid ligands specify different interactions with NF-kappaB by allosteric effects on the glucocorticoid receptor DNA binding domain. J. Biol. Chem. 279 (2004) 50050-50059
35. Gauthier J.M., Bourachot B., Doucas V., Yaniv M., and Moreau-Gachelin F. Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J. 12 (1993) 5089-5096
36. Ghisletti S., Huang W., Ogawa S., Pascual G., Lin M.E., Willson T.M., Rosenfeld M.G., and Glass C.K. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25 (2007) 57-70
37. Ghogomu S.M., van Venrooy S., Ritthaler M., Wedlich D., and Gradl D. HIC-5 is a novel repressor of lymphoid enhancer factor/T-cell factor-driven transcription. J. Biol. Chem. 281 (2006) 1755-1764
38. Gonzalez M.V., Jimenez B., Berciano M.T., Gonzalez-Sancho J.M., Caelles C., Lafarga M., and Munoz A. Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution. J. Cell Biol. 150 (2000) 1199-1208
39. Griekspoor A., Zwart W., Neefjes J., and Michalides R. Visualizing the action of steroid hormone receptors in living cells. Nucl. Receptor Signal. 5 (2007) e003
40. Gronemeyer H., Gustafsson J.A., and Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov. 3 (2004) 950-964
41. Hasegawa Y., Tomita K., Watanabe M., Yamasaki A., Sano H., Hitsuda Y., and Shimizu E. Dexamethasone inhibits phosphorylation of histone H3 at serine 10. Biochem. Biophys. Res. Commun. 336 (2005) 1049-1055
42. He Y., and Simons Jr. S.S. STAMP, a novel predicted factor assisting TIF2 actions in glucocorticoid receptor-mediated induction and repression. Mol. Cell. Biol. 27 (2007) 1467-1485
43. Heck S., Bender K., Kullmann M., Göttlicher M., Herrlich P., and Cato A.C. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J. 16 (1997) 4698-4707
44. Heck S., Kullmann M., Gast A., Ponta H., Rahmsdorf H.J., Herrlich P., and Cato A.C. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13 (1994) 4087-4095
45. Hirasawa N., Sato Y., Fujita Y., Mue S., and Ohuchi K. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells. J. Immunol. 161 (1998) 4939-4943
46. Hoberg J.E., Popko A.E., Ramsey C.S., and Mayo M.W. IκB kinase α-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol. Cell. Biol. 26 (2006) 457-471
47. Hoberg J.E., Yeung F., and Mayo M.W. SMRT derepression by the IκB kinase α: a prerequisite to NF-κB transcription and survival. Mol. Cell 16 (2004) 245-255
48. Huang S.M., and Cheng Y.S. Analysis of two CBP (cAMP-response-element-binding protein-binding protein) interacting sites in GRIP1 (glucocorticoid-receptor-interacting protein), and their importance for the function of GRIP1. Biochem. J. 382 (2004) 111-119
49. Hulley P.A., Gordon F., and Hough F.S. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases. Endocrinology 139 (1998) 2423-2431
50. Hurley D.M., Accili D., Stratakis C.A., Karl M., Vamvakopoulos N., Rorer E., Constantine K., Taylor S.I., and Chrousos G.P. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance. J. Clin. Invest. 87 (1991) 680-686
51. Ichijo T., Voutetakis A., Cotrim A.P., Bhattachryya N., Fujii M., Chrousos G.P., and Kino T. The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J. Biol. Chem. 280 (2005) 42067-42077
52. Imai E., Miner J.N., Mitchell J.A., Yamamoto K.R., and Granner D.K. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J. Biol. Chem. 268 (1993) 5353-5356
53. Imasato A., Desbois-Mouthon C., Han J., Kai H., Cato A.C., Akira S., and Li J.D. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J. Biol. Chem. 277 (2002) 47444-47450
54. Ito K., Barnes P.J., and Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell. Biol. 20 (2000) 6891-6903
55. Ito K., Jazrawi E., Cosio B., Barnes P.J., and Adcock I.M. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J. Biol. Chem. 276 (2001) 30208-30215
56. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., and Adcock I.M. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 203 (2006) 7-13
57. Jee Y.K., Gilmour J., Kelly A., Bowen H., Richards D., Soh C., Smith P., Hawrylowicz C., Cousins D., Lee T., and Lavender P. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J. Biol. Chem. 280 (2005) 23243-23250
58. Jenkins B.D., Pullen C.B., and Darimont B.D. Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol. Metab. 12 (2001) 122-126
59. Jonat C., Rahmsdorf H.J., Park K.K., Cato A.C., Gebel S., Ponta H., and Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62 (1990) 1189-1204
60. Kadrmas J.L., and Beckerle M.C. The LIM domain: from the cytoskeleton to the nucleus. Nat. Rev. Mol. Cell. Biol. 5 (2004) 920-931
61. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S.C., Heyman R.A., Rose D.W., Glass C.K., and Rosenfeld M.G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403-414
62. Karin M., Haslinger A., Holtgreve H., Richards R.I., Krauter P., Westphal H.M., and Beato M. Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature 308 (1984) 513-519
63. Karrasch T., Steinbrecher K.A., Allard B., Baldwin A.S., and Jobin C. Wound-induced p38MAPK-dependent histone H3 phosphorylation correlates with increased COX-2 expression in enterocytes. J. Cell. Physiol. 207 (2006) 809-815
64. Karst H., Karten Y.J., Reichardt H.M., de Kloet E.R., Schutz G., and Joels M. Corticosteroid actions in hippocampus require DNA binding of glucocorticoid receptor homodimers. Nat. Neurosci. 3 (2000) 977-978
65. Kassel O., Sancono A., Kratzschmar J., Kreft B., Stassen M., and Cato A.C. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20 (2001) 7108-7116
66. Kassel O., Schneider S., Heilbock C., Litfin M., Göttlicher M., and Herrlich P. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-κB-regulated promoters. Genes Dev. 18 (2004) 2518-2528
67. Kellendonk C., Tronche F., Reichardt H.M., Bauer A., Greiner E., Schmid W., and Schutz G. Analysis of glucocorticoid receptor function in the mouse by gene targeting. Ernst Schering Res. Found. Workshop (2002) 305-318
68. Kerppola T.K., Luk D., and Curran T. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13 (1993) 3782-3791
69. Ki S.H., Cho I.J., Choi D.W., and Kim S.G. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPβ TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol. Cell. Biol. 25 (2005) 4150-4165
70. König H., Ponta H., Rahmsdorf H.J., and Herrlich P. Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11 (1992) 2241-2246
71. Kucera T., Waltner-Law M., Scott D.K., Prasad R., and Granner D.K. A point mutation of the AF2 transactivation domain of the glucocorticoid receptor disrupts its interaction with steroid receptor coactivator 1. J. Biol. Chem. 277 (2002) 26098-26102
72. Kunz S., Sandoval R., Carlsson P., Carlstedt-Duke J., Bloom J.W., and Miesfeld R.L. Identification of a novel glucocorticoid receptor mutation in budesonide-resistant human bronchial epithelial cells. Mol. Endocrinol. 17 (2003) 2566-2582
73. Kuo M.H., and Allis C.D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessay 20 (1998) 615-626
74. Kutoh E., Stromstedt P.E., and Poellinger L. Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1. Mol. Cell. Biol. 12 (1992) 4960-4969
75. Kwok R.P., Lundblad J.R., Chrivia J.C., Richards J.P., Bachinger H.P., Brennan R.G., Roberts S.G., Green M.R., and Goodman R.H. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370 (1994) 223-226
76. Lasa M., Abraham S.M., Boucheron C., Saklatvala J., and Clark A.R. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell. Biol. 22 (2002) 7802-7811
77. Lasa M., Brook M., Saklatvala J., and Clark A.R. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol. Cell. Biol. 21 (2001) 771-780
78. Lechner J., Welte T., Tomasi J.K., Bruno P., Cairns C., Gustafsson J., and Doppler W. Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J. Biol. Chem. 272 (1997) 20954-20960
79. Lee S.K., Kim H.J., Na S.Y., Kim T.S., Choi H.S., Im S.Y., and Lee J.W. Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J. Biol. Chem. 273 (1998) 16651-16654
80. Lerner L., Henriksen M.A., Zhang X., and Darnell Jr. J.E. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 17 (2003) 2564-2577
81. Liberman A.C., Refojo D., Druker J., Toscano M., Rein T., Holsboer F., and Arzt E. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 21 (2007) 1177-1188
82. Liden J., Delaunay F., Rafter I., Gustafsson J., and Okret S. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J. Biol. Chem. 272 (1997) 21467-21472
83. Liu J.L., Papachristou D.N., and Patel Y.C. Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway. Biochem. J. 301 (1994) 863-869
84. Liu P.-Y., Hsieh T.-Y., Chou W.-Y., and Huang S.-M. Modulation of glucocorticoid receptor-interacting protein 1 (GRIP1) transactivation and co-activation activities through its C-terminal repression and self-association domains. FEBS J. 273 (2006) 2172-2183
85. Lucibello F.C., Slater E.P., Jooss K.U., Beato M., and Muller R. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J. 9 (1990) 2827-2834
86. Luecke H.F., and Yamamoto K.R. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev. 19 (2005) 1116-1127
87. Ma Z., Shah R.C., Chang M.J., and Benveniste E.N. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 24 (2004) 5496-5509
88. Martens C., Bilodeau S., Maira M., Gauthier Y., and Drouin J. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol. Endocrinol. 19 (2005) 885-897
89. Martens J.A., and Winston F. Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Cur. Opin. Genet. Dev. 13 (2003) 136-142
90. Martens J.H., Verlaan M., Kalkhoven E., and Zantema A. Cascade of distinct histone modifications during collagenase gene activation. Mol. Cell. Biol. 23 (2003) 1808-1816
91. McKay L.I., and Cidlowski J.A. Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol. Endocrinol. 12 (1998) 45-56
92. McKay L.I., and Cidlowski J.A. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol. Endocrinol. 14 (2000) 1222-1234
93. Miao F., Li S., Chavez V., Lanting L., and Natarajan R. Coactivator-associated arginine methyltransferase-1 enhances Nuclear Factor-κB-mediated gene transcription through methylation of histone H3 at arginine 17. Mol. Endocrinol. 20 (2006) 1562-1573
94. Miksicek R., Borgmeyer U., and Nowock J. Interaction of the TGGCA-binding protein with upstream sequences is required for efficient transcription of mouse mammary tumor virus. EMBO J. 6 (1987) 1355-1360
95. Miner J.N. Designer glucocorticoids. Biochem. Pharmacol. 64 (2002) 355-361
96. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., and Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269 (1994) 13289-13295
97. Mullick J., Anandatheerthavarada H.K., Amuthan G., Bhagwat S.V., Biswas G., Camasamudram V., Bhat N.K., Reddy S.E., Rao V., and Avadhani N.G. Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter. J. Biol. Chem. 276 (2001) 18007-18017
98. Na S.-Y., Lee S.-K., Han S.-J., Choi H.-S., Im S.-Y., and Lee J.W. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappa B-mediated transactivations. J. Biol. Chem. 273 (1998) 10831-10834
99. Nie M., Knox A.J., and Pang L. Beta2-adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J. Immunol. 175 (2005) 478-486
100. Nissen R.M., and Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14 (2000) 2314-2329
101. Novak A., and Dedhar S. Signaling through beta-catenin and Lef/Tcf. Cell. Mol. Life Sci. 56 (1999) 523-537
102. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., and Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122 (2005) 707-721
103. Ogawa S., Lozach J., Jepsen K., Sawka-Verhelle D., Perissi V., Sasik R., Rose D.W., Johnson R.S., Rosenfeld M.G., and Glass C.K. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14461-14466
104. Ohnaka K., Tanabe M., Kawate H., Nawata H., and Takayanagi R. Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts. Biochem. Biophys. Res. Commun. 329 (2005) 177-181
105. Ohnaka K., Taniguchi H., Kawate H., Nawata H., and Takayanagi R. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem. Biophys. Res. Commun. 318 (2004) 259-264
106. Oitzl M.S., Reichardt H.M., Joels M., and de Kloet E.R. Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12790-12795
107. Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 (1995) 1354-1357
108. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., and Glass C.K. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437 (2005) 759-763
109. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., and Nabel G.J. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275 (1997) 523-527
110. Pfitzner E., Jahne R., Wissler M., Stoecklin E., and Groner B. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. Mol. Endocrinol. 12 (1998) 1582-1593
111. Philips A., Maira M., Mullick A., Chamberland M., Lesage S., Hugo P., and Drouin J. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol. 17 (1997) 5952-5959
112. Prefontaine G.G., Lemieux M.E., Giffin W., Schild-Poulter C., Pope L., LaCasse E., Walker P., and Hache R.J. Recruitment of octamer transcription factors to DNA by glucocorticoid receptor. Mol. Cell. Biol. 18 (1998) 3416-3430
113. Prigent C., and Dimitrov S. Phosphorylation of serine 10 in histone H3, what for?. J. Cell Sci. 116 (2003) 3677-3685
114. Ray A., LaForge K.S., and Sehgal P.B. Repressor to activator switch by mutations in the first Zn finger of the glucocorticoid receptor: is direct DNA binding necessary?. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7086-7090
115. Ray A., and Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 752-756
116. Ray D.W., Suen C.S., Brass A., Soden J., and White A. Structure/function of the human glucocorticoid receptor: tyrosine 735 is important for transactivation. Mol. Endocrinol. 13 (1999) 1855-1863
117. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., and Schütz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 (1998) 531-541
118. Reichardt H.M., Tuckermann J.P., Göttlicher M., Vujic M., Weih F., Angel P., Herrlich P., and Schutz G. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J. 20 (2001) 7168-7173
119. Reily M.M., Pantoja C., Hu X., Chinenov Y., and Rogatsky I. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 25 (2006) 108-117
120. Rider L.G., Hirasawa N., Santini F., and Beaven M.A. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J. Immunol. 157 (1996) 2374-2380
121. Rogatsky I., Luecke H.F., Leitman D.C., and Yamamoto K.R. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16701-16706
122. Rogatsky I., Wang J.C., Derynck M.K., Nonaka D.F., Khodabakhsh D.B., Haqq C.M., Darimont B.D., Garabedian M.J., and Yamamoto K.R. Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 13845-13850
123. Rogatsky I., Zarember K.A., and Yamamoto K.R. Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J. 20 (2001) 6071-6083
124. Sakai D.D., Helms S., Carlstedt-Duke J., Gustafsson J.A., Rottman F.M., and Yamamoto K.R. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2 (1988) 1144-1154
125. Savkur R.S., and Burris T.P. The coactivator LXXLL nuclear receptor recognition motif. J. Pept. Res. 63 (2004) 207-212
126. Schaaf M.J., and Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid. Biochem. Mol. Biol. 83 (2002) 37-48
127. Schäcke H., Rehwinkel H., Asadullah K., and Cato A.C. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index. Exp. Dermatol. 15 (2006) 565-573
128. Scheinman R.I., Gualberto A., Jewell C.M., Cidlowski J.A., and Baldwin Jr. A.S. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15 (1995) 943-953
129. Schena M., Freedman L.P., and Yamamoto K.R. Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev. 3 (1989) 1590-1601
130. Schoneveld O.J., Gaemers I.C., and Lamers W.H. Mechanisms of glucocorticoid signalling. Biochim. Biophys. Acta 1680 (2004) 114-128
131. Schüle R., Rangarajan P., Kliewer S., Ransone L.J., Bolado J., Yang N., Verma I.M., and Evans R.M. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62 (1990) 1217-1226
132. Shemshedini L., Knauthe R., Sassone-Corsi P., Pornon A., and Gronemeyer H. Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J. 10 (1991) 3839-3849
133. Sheppard K.A., Phelps K.M., Williams A.J., Thanos D., Glass C.K., Rosenfeld M.G., Gerritsen M.E., and Collins T. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J. Biol. Chem. 273 (1998) 29291-29294
134. Shi Y., and Gaestel M. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 383 (2002) 1519-1536
135. Simone C. SWI/SNF: the crossroads where extracellular signaling pathways meet chromatin. J. Cell. Physiol. 207 (2006) 309-314
136. Sims III R.J., Belotserkovskaya R., and Reinberg D. Elongation by RNA polymerase II: the short and long of it. Genes Dev. 18 (2004) 2437-2468
137. Smith E., and Frenkel B. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner. J. Biol. Chem. 280 (2005) 2388-2394
138. Song C.Z., Tian X., and Gelehrter T.D. Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 11776-11781
139. Stauber C., Altschmied J., Akerblom I.E., Marron J.L., and Mellon P.L. Mutual cross-interference between glucocorticoid receptor and CREB inhibits transactivation in placental cells. New Biol. 4 (1992) 527-540
140. Stevens A., Garside H., Berry A., Waters C., White A., and Ray D. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Mol. Endocrinol. 17 (2003) 845-859
141. Stöcklin E., Wissler M., Gouilleux F., and Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383 (1996) 726-728
142. Stoecklin E., Wissler M., Moriggl R., and Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol. Cell. Biol. 17 (1997) 6708-6716
143. Strömstedt P.E., Poellinger L., Gustafsson J.A., and Carlstedt-Duke J. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol. Cell. Biol. 11 (1991) 3379-3383
144. Subramaniam N., Cairns W., and Okret S. Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1. J. Biol. Chem. 273 (1998) 23567-23574
145. Swantek J.L., Cobb M.H., and Geppert T.D. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol. Cell. Biol. 17 (1997) 6274-6282
146. Takeda T., Kurachi H., Yamamoto T., Nishio Y., Nakatsuji Y., Morishige K., Miyake A., and Murata Y. Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J. Endocrinol. 159 (1998) 323-330
147. Touray M., Ryan F., Jaggi R., and Martin F. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun. Oncogene 6 (1991) 1227-1234
148. Tuckermann J.P., Kleiman A., McPherson K.G., and Reichardt H.M. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 42 (2005) 71-104
149. Tuckermann J.P., Kleiman A., Moriggl R., Spanbroek R., Neumann A., Illing A., Clausen B.E., Stride B., Förster I., Habenicht A.J.R., Reichardt H.M., Tronche F., Schmid W., and Schütz G. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J. Clin. Invest. 117 (2007) 1381-1390
150. Tuckermann J.P., Reichardt H.M., Arribas R., Richter K.H., Schutz G., and Angel P. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J. Cell Biol. 147 (1999) 1365-1370
151. Umesono K., and Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57 (1989) 1139-1146
152. Vanden Berghe W., De Bosscher K., Vermeulen L., De Wilde G., and Haegeman G. Induction and repression of NF-kappa B-driven inflammatory genes. Ernst Schering Res. Found. Workshop (2002) 233-278
153. Weiss C., Schneider S., Wagner E.F., Zhang X., Seto E., and Bohmann D. JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J. 22 (2003) 3686-3695
154. Wieland S., Dobbeling U., and Rusconi S. Interference and synergism of glucocorticoid receptor and octamer factors. EMBO J. 10 (1991) 2513-2521
155. Wietek C., Miggin S.M., Jefferies C.A., and O'Neill L.A.J. Interferon regulatory factor-3-mediated activation of the interferon-sensitive response element by Toll-like receptor (TLR) 4 but not TLR3 requires the p65 subunit of NF-κB. J. Biol. Chem. 278 (2003) 50923-50931
156. Wu H.-Y., Hamamori Y., Xu J., Chang S.C., Saluna T., Chang M.-F., O'Malley B.W., and Kedes L. Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD. J. Biol. Chem. 280 (2005) 3129-3137
157. Wu J., Li Y., Dietz J., and Lala D.S. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions. Mol. Endocrinol. 18 (2004) 53-62
158. Xu L., Glass C.K., and Rosenfeld M.G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9 (1999) 140-147
159. Yang L., Guerrero J., Hong H., DeFranco D.B., and Stallcup M.R. Interaction of the tau 2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 11 (2000) 2007-2018
160. Yang-Yen H.F., Chambard J.C., Sun Y.L., Smeal T., Schmidt T.J., Drouin J., and Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62 (1990) 1205-1215